Jack P. Green
Manchester, ENG M139PT, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Inflammatory responses following CRISPR modification of the nuclear localisation sequence in endogenous interleukin-1 alpha.
Journal: Disease models & mechanisms
Published: October 13, 2025
Dehydroisohispanolone alleviates NLRP3-driven inflammation in gout arthritis.
Journal: Biochemical pharmacology
Published: March 21, 2025
Taurine transport is a critical modulator of ionic fluxes during NLRP3 inflammasome activation.
Journal: Cell reports
Published: March 10, 2025
Disruption of macrophage cell volume drives inflammatory responses and type I interferon signaling.
Journal: The Journal of cell biology
Published: November 19, 2024
The NLRP3 inflammasome is essential for IL-18 production in a murine model of macrophage activation syndrome.
Journal: bioRxiv : the preprint server for biology
Published: March 11, 2024
The NLRP3 inflammasome is essential for IL-18 production in a murine model of macrophage activation syndrome.
Journal: Disease models & mechanisms
Published: February 26, 2024
Brazilin is a natural product inhibitor of the NLRP3 inflammasome.
Journal: iScience
Published: October 19, 2023
Proximity labelling of pro-interleukin-1α reveals evolutionary conserved nuclear interactions.
Journal: Nature communications
Published: June 15, 2023
Disruptions in endocytic traffic contribute to the activation of the NLRP3 inflammasome.
Journal: Science signaling
Published: February 22, 2023
DNA-sensing inflammasomes cause recurrent atherosclerotic stroke.
Journal: Nature
Published: January 28, 2023
Last Updated: 09/26/2026